Suven Life Sciences Limited (BOM:530239)
India
· Delayed Price · Currency is INR 289.35
+13.75 (4.99%)
At close: Jul 14, 2025
Suven Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -1,607 | -1,051 | -1,183 | -1,220 | -721.51 | Upgrade
|
Depreciation & Amortization | 53.07 | 64.75 | 65.17 | 43.7 | 43.31 | Upgrade
|
Other Amortization | - | 0.27 | 0.26 | 0.23 | 0.15 | Upgrade
|
Loss (Gain) From Sale of Investments | -49.76 | -45.49 | -17.92 | -3.56 | -0.61 | Upgrade
|
Stock-Based Compensation | 12.75 | - | - | - | - | Upgrade
|
Other Operating Activities | -50.31 | -192.35 | -139.46 | -56.52 | -134.54 | Upgrade
|
Change in Accounts Receivable | -0.51 | -4.79 | 4.91 | 4.64 | 5.09 | Upgrade
|
Change in Inventory | 4.71 | -7.08 | 0.22 | 1.19 | -1.42 | Upgrade
|
Change in Accounts Payable | 31.59 | 4.03 | -3.22 | -10.09 | -27.86 | Upgrade
|
Change in Other Net Operating Assets | 64.86 | 76.73 | 112.9 | -35.02 | -122.85 | Upgrade
|
Operating Cash Flow | -1,541 | -1,155 | -1,160 | -1,275 | -960.24 | Upgrade
|
Capital Expenditures | -372.76 | - | -28.95 | -197.72 | -63.05 | Upgrade
|
Sale of Property, Plant & Equipment | - | 24.21 | - | - | - | Upgrade
|
Investment in Securities | 607.24 | 757.32 | -2,512 | -447.21 | 912.77 | Upgrade
|
Other Investing Activities | 1,315 | 162.83 | 62.64 | 8.14 | -297.11 | Upgrade
|
Investing Cash Flow | 1,550 | 944.36 | -2,478 | -222.29 | 558.4 | Upgrade
|
Long-Term Debt Repaid | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade
|
Total Debt Repaid | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade
|
Net Debt Issued (Repaid) | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade
|
Issuance of Common Stock | - | - | 3,974 | 1,476 | - | Upgrade
|
Other Financing Activities | -0.47 | -1.58 | -2.62 | -3.95 | 361.05 | Upgrade
|
Financing Cash Flow | -7.56 | -10.54 | 3,955 | 1,457 | 348.56 | Upgrade
|
Net Cash Flow | 0.93 | -220.87 | 317.46 | -40.75 | -53.28 | Upgrade
|
Free Cash Flow | -1,914 | -1,155 | -1,189 | -1,473 | -1,023 | Upgrade
|
Free Cash Flow Margin | -2875.39% | -987.51% | -874.42% | -1232.64% | -727.12% | Upgrade
|
Free Cash Flow Per Share | -8.78 | -5.29 | -6.67 | -10.93 | -8.04 | Upgrade
|
Cash Interest Paid | 0.47 | 1.58 | 2.62 | 3.95 | 8.15 | Upgrade
|
Cash Income Tax Paid | -6.05 | -61.77 | 11.02 | 5.2 | 11.45 | Upgrade
|
Levered Free Cash Flow | -1,260 | -684.75 | -826.32 | -616.13 | -702.41 | Upgrade
|
Unlevered Free Cash Flow | -1,259 | -683.76 | -824.52 | -612.81 | -697.32 | Upgrade
|
Change in Net Working Capital | -120.18 | -90.54 | 35.74 | -329.83 | 157.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.